RecruitingNot ApplicableNCT06213805

Efficacy and Safety of Minimally Invasive Micro-Sclerostomy (MIMS) in Glaucoma Surgery


Sponsor

Hôpital Privé de la Baie

Enrollment

23 participants

Start Date

Jan 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The main objective is to evaluate the effectiveness of MIMS in patients with an indication for glaucoma surgery, compared to traditional surgery. The secondary objective is to assess safety. The investigating ophthalmologist will follow the patients and collect clinical data in order to identify the benefits and complications of MIMS. Patients are expected to experience fewer complications compared to traditional glaucoma surgery.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing a minimally invasive glaucoma surgery technique called micro-sclerostomy (MIMS) to help lower eye pressure in people with glaucoma that is not well controlled by eye drops alone. Glaucoma is a condition where high pressure in the eye damages the optic nerve and can lead to vision loss. **You may be eligible if...** - You are 18 or older - You have open-angle glaucoma (including pigmentary or pseudoexfoliative types) with uncontrolled eye pressure despite maximum tolerated eye drop treatment - Your eye angle is open on examination and the conjunctiva (white part of the eye) is healthy without scarring - OR you have chronic angle-closure glaucoma needing combined glaucoma and cataract surgery **You may NOT be eligible if...** - You have other significant eye problems besides cataracts - You have had previous eye surgery (other than cataract removal), eye injury, or scarring in the area planned for surgery - You have neovascular glaucoma (related to abnormal blood vessel growth) - Your vision is very severely reduced (worse than counting fingers) - You are pregnant or breastfeeding - You have severe systemic illnesses that would make surgery unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREMinimally invasive microsclerostomy

MIMS is a filtering glaucoma surgery, which consists of creating a sclero-corneal drainage channel, to allow the flow of aqueous humor and therefore the reduction of intraocular pressure. This surgery is extremely quick, lasting 3 to 5 minutes, according to recent MIMS studies, in contrast to the duration of a trabeculectomy, the classic glaucoma surgery, which varies between 20 and 60 minutes.


Locations(3)

Hôpital Privé de la Baie

Avranches, France

Clinique Thiers

Bordeaux, France

Fondation Rothschild

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06213805


Related Trials